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Introduction: Delayed-onset heparin-induced thrombocytopenia (HIT) is a rare side effect of heparin. This
prothrombotic condition can present its ﬁrst signs up to three weeks following heparin administration
even if heparin use has been stopped.
Report: A 54-year-old claudicant patient underwent a suprageniculate limb bypass with heparin
administration. Despite bypass patency, our patient developed recurrent wound necrosis and kept
complaining of ischemic pain. The patient then developed toe necrosis and underwent leg amputation.
Conclusion: Delayed-onset HIT is a rare condition that should be looked for and promptly managed in
patients with peripheral vasculopathy following heparin administration.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd.Introduction
Delayed-onset heparin-induced thrombocytopenia (HIT) is
a rare side effect of heparin. In contrast to classical HIT, this pro-
thrombotic condition can present its ﬁrst signs up to three weeks
following heparin administration even if heparin use has been
stopped.1
We report the case of a claudicant patient who underwent
suprageniculate bypass surgery. The patient developed delayed
onset HIT that caused wound dehiscence and necrosis. Despite
aggressive multidisciplinary management, the patient developed
distal toe and leg necrosis.Report
A 54-year-old man with a past history of diabetes mellitus type
II and hypertension presented with bilateral peripheral arterial
disease. He could not walk more than 200 m without calf pain
(Fountain IIB), with a signiﬁcant stenosis of the left superﬁcial
femoral artery and an extensive occlusion of the right superﬁcial
femoral artery. We performed a right suprageniculate femoro-
popliteal vein bypass as well as a percutaneous angioplasty and
stent implantation of the left superﬁcial femoral artery.34 25
ery. Published by Elsevier Ltd. OpUnfractionated heparin 3 500 UI was given during surgery. The
initial evolution was uneventful and the patient was discharged at
day 7. Postoperative angiological examination showed improved
ankle plethysmography of 55 mmHg on the right and 65 mmHg on
the left (35 and 50 mmHg in the preoperative setting respectively).
Three weeks following hospital discharge, the patient developed
bilateral limb claudication with a hanging livedo. All surgical scars
of the femoro-popliteal bypass were necrotic and the 3 ﬁrst toes
were also cyanotic (Figs. 1 and 2). An angiological exam showed
that the left femoral artery stent was still patent as was the femoro-
popliteal bypass on the right. Immunological and hematological
workups were done and were normal. After a multidisciplinary
approach, delayed-onset HIT was suspected based on high anti-PF4
antibodies (4 times threshold values) and, retrospectively, a platelet
count showed a biphasic proﬁle with a decrease of more than 30
percent. Heparin administration was stopped and replaced by
fondaparinux. The patient mostly complained of pain in both feet
and legs that was difﬁcult to control with morphine derivatives,
pregabalin (Lyrica) and haloperidol (Haldol), and then clonidine
(Catapresan) and duloxetine (Cymbalta) were also testedwith no
beneﬁt. Five months following initial surgery, the patient presented
with increased pain that predominated on the right side, with
a vascular workup that showed partial thrombosis in the abdominal
aorta and both iliac arteries. The patient underwent therapeutic
doses of fondaparinux and a transmetatarsian amputation was
undertaken because of critical ischemia of the right fore-foot.
During this procedure, the patient developed cardiac ischemia
and underwent a coronography that showed a severe bitroncularen access under CC BY-NC-ND license. 
Figure 1. Wound necrosis at 9 weeks.
Figure 2. Fore-foot ischemia at 9 weeks with a hanging livedo.
G. Herren, C. Haller / EJVES Extra 24 (2012) e34ee35 e35disease treated by angioplasty. During the following weeks, the
ischemic condition of the patient progressed. A Burgess amputation
was performed on the right side because of critical ischemiaprogression and a transmetatarsian amputation on the left through
wet necrosis of all toes.
Discussion
Delayed-onset HIT is a rare condition that shares some of the
pathophysiology of the more classical HIT. However, unlike clas-
sical, which develops in 48 h, delayed-onset HIT becomes clinically
detectable 9.2 days (range, 5e19 days) following heparin exposure.
Most common complications are venous thromboembolism or
thrombosis of arteries or arterial grafts.2,3 Our patient presented
a microangiopathy with partial thrombosis of the abdominal aorta
and both iliac arteries and ischemic pain of the lower limbs. He also
developed this condition much later after heparin administration.
The outcome was dramatic with multi-organ vessel thrombosis.
This atypical HIT presentation made the diagnosis difﬁcult. Also,
late recognition of delayed-onset HIT generated major morbidity
with stump necrosis and major amputation. Our claudicant patient
underwent major limb amputation 7 months after initial surgery
because of atypical status and delayed diagnosis. Currently dana-
paroid is the recommended treatment of choice in situations of HIT.
We used fondaparinux, which was easily available in our hospital
and was an effective therapy, although rare cases of HIT during
fondaparinux prophylaxis have been reported.4,5 Our suspicion of
delayed-onset HIT was based on the late onset of thrombosis, the
positive anti-PF4 antibodies and the drop in platelet count.
Conclusion
Delayed-onset HIT is a rare condition which is difﬁcult to diag-
nose and can cause dramatic outcomes. In this case report, a clau-
dicant patient developed delayed-onset HIT after heparin
exposition during bypass surgery, and developed severe ischemia
in the limbs resulting in bilateral amputation and coronary disease.
This syndrome should be part of the differential diagnosis of diffuse
arteriopathy in all patients that have been exposed to heparin in
previous weeks. Anti-coagulation therapy should begin with fon-
daparinux or danaparoid. Despite recognition, adequate therapies
are very limited with a high risk of death, of about 20 percent.2,3
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